Coronavirus (COVID-19)
Learn more
March 13, 2013
Location: The Hospital of Central Connecticut
A Phase II evaluation of Ixabepilone in the treatment of recurrent or persistent Leiomyosarcoma of the Uterus.
Get the latest healthcare news directly in your inbox.
To receive our health news text alerts / text StartHere to 85209